Product Images Fentanyl Buccal
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 18 images provide visual information about the product associated with Fentanyl Buccal NDC 51862-638 by Mayne Pharma, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a graph showing the plasma concentration of fentanyl (a pain medication) over time after administration of a 400 mcg buccal tablet or a normalized equivalent dose of Actiq (another form of fentanyl). The x-axis represents time in hours and the y-axis shows the plasma fentanyl concentration in ng/mL. The graph shows an initial rapid increase in concentration followed by a gradual decline over several hours.*
This appears to be a chart that shows the plasma Fentanyl concentration (in ng/mL) over time (in hours) after administration of various doses (100 mcg, 200 mcg, 400 mcg, and 800 mcg).*
This appears to be a graph or chart showing the time from administration of study drug (in minutes) for Fentanyl Buccal Tablets and Placebo. The chart seems to have four time points, indicated as 15, 30, 45, and 60 minutes. Without additional information, it is not possible to provide further context or interpretation.*
This is a medication label for Fentanyl Buccal Tablets. The drug is only available through a restricted program called the TIRF REMS Access program. The medication should only be supplied through this program and instructions for use are provided. Each tablet contains fentanyl clrate equivalent to 100 mcg fentanyl base. The label warns to keep the medication out of reach of children and not to substitute it for other fentanyl products. Dosage instructions are provided, and 28 Buccal Tablets are included in the package.*
This is a pharmaceutical label for Fentanyl Buccal Tablets, which are only available through a restricted program called TIRF REMS Access, and must not be given to someone for whom the tablets were not prescribed. The label instructs the patient to read the included medication guide and warns to keep the tablets out of reach of children. It also gives details on the product, including the contents of each tablet, proper storage procedures, and usage instructions. There also appears to be some additional text that is not discernible due to errors.*
This is a pharmacy label for Fentanyl Buccal Tablets. The medication is available through a restricted program called 'the TIRF REMS Access program. Patients need to contact the program for more information. It is advised not to substitute Fentanyl Buccal Tablets it for other Fentanyl products. This medication can be harmful or fatal if given to someone for whom it was not prescribed. The tablet should not be swallowed or chewed. It is necessary to store the medication at a place with a temperature between 20°C and 25°C. Patients are advised to read the enclosed Fentanyl Buccal Tablets Medication Guide. The usual dosage is mentioned in the package insert. The remaining text seems to be incorrect output.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.